Cargando…
The clinical relevance of outcomes used in late-onset Pompe disease: can we do better?
Pompe disease/glycogen storage disease type II, is a rare, lysosomal storage disorder associated with progressive proximal myopathy, causing a gradual loss of muscular function and respiratory insufficiency. Studies of patients with late-onset Pompe disease have used endpoints such as the 6-minute w...
Autores principales: | Lachmann, Robin, Schoser, Benedikt |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4015278/ https://www.ncbi.nlm.nih.gov/pubmed/24119230 http://dx.doi.org/10.1186/1750-1172-8-160 |
Ejemplares similares
-
Alglucosidase alfa: 5 years of experience in late-onset Pompe disease
por: Schoser, Benedikt
Publicado: (2013) -
The impact of interrupting enzyme replacement therapy in late-onset Pompe disease
por: Wenninger, Stephan, et al.
Publicado: (2021) -
Pregnancy Outcomes in Late Onset Pompe Disease
por: Goker-Alpan, Ozlem, et al.
Publicado: (2020) -
Small fiber involvement is independent from clinical pain in late-onset Pompe disease
por: Enax-Krumova, Elena K., et al.
Publicado: (2022) -
Hypothyroidism in late-onset Pompe disease
por: Schneider, Joseph, et al.
Publicado: (2016)